Periprocedural Mortality Risk After Elective Atrial Fibrillation Ablation in Japan - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Mortality Risks Associated with Elective Atrial Fibrillation Ablation Procedures in Japan

  • By

  • Koichi Inoue

  • Koshiro Kanaoka

  • Yasunori Ueda

  • Haruhiko Abe

  • Kuniyasu Ikeoka

  • Tsuyoshi Mishima

  • Tatsuhisa Ozaki

  • Takuya Ohashi

  • Satoshi Osaki

  • Yoko Sumita

  • Yoshitaka Iwanaga

  • Yasushi Matsumura

  • Yasushi Sakata

  • August 29, 2026

Share

Mortality Risks Associated with Elective Atrial Fibrillation Ablation Procedures in Japan

Overview

This study utilizes the JROAD-DPC database to assess periprocedural mortality rates for elective atrial fibrillation ablation in Japan, aiming to establish a contemporary benchmark.

Background

Elective atrial fibrillation (AF) ablation is a common intervention. Understanding its safety profile is crucial, particularly in light of conflicting mortality data from various studies. The JROAD-DPC database provides a unique opportunity to analyze these risks.

Data Highlights

No numerical data provided in the source material, which limits the ability to quantify findings.

Key Findings

  • The JROAD-DPC database offers a comprehensive view of elective AF ablation outcomes in Japan.
  • Mortality estimates for AF ablation vary significantly, with reported rates ranging from 0.05% to 0.46% across different studies.
  • High-volume centers report lower in-hospital mortality rates compared to lower-volume centers.
  • Evidence suggests a potential diffusion penalty affecting procedural safety as AF ablation becomes more routine.

Clinical Implications

The findings provide data on mortality risks associated with elective AF ablation.

Conclusion

This study provides data on the safety of elective AF ablation in Japan, addressing discrepancies in mortality data.

Related Resources & Content

  1. Periprocedural Mortality Risk After Elective Atrial Fibrillation Ablation in Japan | Cardiology | JAMA Network
  2. Impact of Comorbidity on Mortality and Readmission Rates in Patients with Existing Implantable Pacemakers Undergoing Catheter Ablation: Insights from the German Ablation Registry
  3. Sex Differences in Postsurgery AF Incidence and Mortality
  4. Outcomes of Direct Oral Anticoagulants Compared to Warfarin in Japanese Patients Aged 85 and Older with Atrial Fibrillation: Findings from a Single-Center Observational Study
  5. Evaluating Safety and Patient-Reported Outcomes in Initial Versus Repeat Ablation for Atrial Fibrillation: Findings from the German Ablation Registry
  6. Key messages
  7. Key messages
  8. Periprocedural Mortality Risk After Elective Atrial Fibrillation Ablation in Japan | Cardiology | JAMA Network Open | JAMA Network
  9. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial | Cardiology | JAMA | JAMA Network

Original Source(s)

Periprocedural Mortality Risk After Elective Atrial Fibrillation Ablation in Japan

  • by Koichi Inoue, Koshiro Kanaoka, Yasunori Ueda, Haruhiko Abe, Kuniyasu Ikeoka, Tsuyoshi Mishima, Tatsuhisa Ozaki, Takuya Ohashi, Satoshi Osaki, Yoko Sumita, Yoshitaka Iwanaga, Yasushi Matsumura, Yasushi Sakata

  • August 29, 2026

Related Content

Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis

Sensitivity and specificity of speckle tracking echocardiography for coronary artery disease: a systematic review and meta-analysis

Baptist Health Heart & Vascular Care to Host 43rd Annual Echocardiography and Structural Heart Symposium

Baptist Health South Florida will host the Baptist Health Heart & Vascular Care 43rd Annual Echocardiography and Structural Heart Symposium on Oct. 2-3 at the Loews Coral Gables Hotel.

  • by

  • August 28, 2026

  • 4 min